The first invited talk of the afternoon is from Owen Sansom 🏳️‍🌈 of CRUK Scotland Inst UofG Cancer Sciences University of Glasgow on Wnt pathway mutations in colon and liver cancer.

#WntUK2024

In-depth discussions with professionals in the field, a fully enjoyable experience, thanks for Alex Tonks and his PhD Alanazi 😬😬😬

Poster session up and running. Real buzz down at #BSH2024

Fully immersed in #BSH2024 in Liverpool. Ready for poster session this evening (PO15), plenty still to hear about before then. Good luck Jessica, our representative PGR from POG Research UofG Cancer Sciences

We are back! ☀️
We were in San Diego at AACR presenting our work and enjoying everyone else’s!
Kathryn A F Pennel presented her work on therapeutic biomarkers in colorectal cancer, while Gerard Lynch represented INCISE with a poster on predictive biomarkers!

Wonderful PhD opportunity in Glasgow with a brilliant supervisor and a great team. Intriguing topic too…RadNetCRUKGlasgow UofG Cancer Sciences Cancer Research UK in Scotland

Join us to explore how radiotherapy affect metastasis in pancreatic cancer in this fantastic opportunity at the CRUK Scotland Centre ⬇️⬇️
@CRUKSI UofG Cancer Sciences
findaphd.com/phds/project/f…

We were delighted to welcome Alex Tonks (Cardiff) to Glasgow, who presented the Tessa Holyoake Memorial lecture this lunchtime with POG Research in attendance and colleagues from UofG Cancer Sciences. Great to learn about new therapeutic directions in AML. Thanks Alex!

📣Abstract deadline extension📣

The abstract deadline for oral and poster presentations at the Beatson International Cancer Conference 2024 has been extended!

📅Submit yours by 31 May 2024

🔗Visit our website to find out how: crukscotlandinstitute.ac.uk/events/beatson…

#BICC2024

Looking forward to speaking about our 3D in vitro model of #glioblastoma at this launch of the NC3Rs Oncology Network.
Recently refined for medium throughput evaluation of #RTdrugcombo with clonogenic survival as readout
rb.gy/kr44y1

#3Dtrumps2D

🤝We have just launched a 5-year partnership with DEBRA UK to develop pre-clinical cancer models that will help increase understanding around the progression of skin cancer in patients living with recessive dystrophic epidermolysis bullosa (RDEB)
debra.org.uk/news/debra-uk-…

Register now for our Oncology Network launch to accelerate adoption of 3Rs approaches across the research community. The meeting agenda is now live. Chaired by Prof Owen Sansom it includes a keynote talk from Anthony Chalmers 💙.
🗓️ 20 May 2024
nc3rs.org.uk/events/oncolog…

Check out this piece from PREDICT-Meso co-I Daniel J. Murphy on the importance of of Genetically Engineered Mouse Models (GEMM) 💎 and how they support #CancerResearch

#Mesothelioma GEMM are vital to #PREDICTMeso WP3 & WP4 and our aims to discover better mesothelioma treatments

The April2024 PREDICT-Meso Newsletter is now live
sway.cloud.microsoft/23cXERCrgbw1AN…
This edition features updates on work packages, a new exciting collaboration & photos of our PREDICT-Meso visit to Scottish Parliament
#mesothelioma #MesotheliomaResearch #PREDICTMeso #PREDICTMeso Newsletter

I you would like to apply through this fellowship to come join our team CRUK Scotland Inst looking at metastasis in colorectal cancer, get in touch!

📣 Just 2 days left to register for the IPSCC! 📣
Join us for enlightening talks from leading experts in the field. Seize this opportunity to connect and learn! Register now! #IPSCC #BerlinConference #MDC #CancerResearch
ipscconference.org

In a session on novel agents & emerging therapeutic strategies at #AACR24 , Jonathan Yang (Memorial Sloan Kettering Cancer Center) presents data on the safety & efficacy of AZD1390 + radiation therapy for #Glioblastoma , co-authored by Anthony Chalmers 💙 (@UofGlasgow): bit.ly/3Pxjony

UofG MVLS

Jonathan Yang presents our phase I data:
AZD1390 very well tolerated in combination with #radiotherapy for #glioblastoma
Promising survival (>12 months) in recurrent GBM
Survival data for newly diagnosed patients maturing
Very excited about this RT-ATM inhibitor combination! #btsm

Learn more about the Ki67 proliferation index in pre-malignant colonic adenomas and the implications for new biomarker testing to predict metachronous disease at Gerard's poster on the INCISE project.

📌 Stop by section 31 to learn more.

University of Glasgow | #AACR24

Visit Nigel's poster to learn more about his research into multi-omic, multi-scale characterisation of colorectal cancer and how this defines spatiotemporal patterns of recurrence.

📌 Stop by section 41 to learn more.

CRUK Scotland Inst | #AACR24